Kinetics of folate and one-carbon metabolism

Folate in Health and Disease, Second Edition

Volumn , Issue , 2009, Pages 491-516

  Gregory, Jesse F ^a   da Silva, Vanessa R ^a   Lamers, Yvonne ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882307300     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (118)

1. O’Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA, Cerda JJ, Gregory JF. Controlled dietary folate affects folate status in nonpregnant women. J Nutr 1995; 125:2717-25.
2. Caudill MA, Cruz AC, Gregory JF, Hutson AD, Bailey LB. Folate status response to controlled folate intake in pregnant women. J Nutr 1997; 127:2363-70.
3. Kauwell GP, Lippert BL, Wilsky CE, Herrlinger-Garcia K, Hutson AD, Theriaque DW, Rampersaud GC, Cerda JJ, Bailey LB. Folate status of elderly women following moderate folate depletion responds only to a higher folate intake. J Nutr 2000; 130:1584-90.
4. Shelnutt KP, Kauwell GP, Chapman CM, Gregory JF 3rd, Maneval DR, Browdy AA, Theriaque DW, Bailey LB. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C→T polymorphism in young women. J Nutr 2003; 133:4107-11.
5. Perry CA, Renna SA, Khitun E, Ortiz M, Moriarty DJ, Caudill MA. Ethnicity and race influence the folate status response to controlled folate intakes in young women. J Nutr 2004; 134:1786-92.
6. 2]folic acid: Isotopic labeling of urinary folate and the catabolite para-acetamidobenzoylglutamate indicates slow, intake-dependent, turnover of folate pools. J Nutr 1998; 128:1896-906.
7. Gregory JF, Quinlivan EP. In vivo kinetics of folate metabolism. Annu Rev Nutr 2002; 22:199-220.
8. Anderson JH, Kerr DJ, Setanoians A, Cooke TG, McArdle CS. A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid. Br J Cancer 1992; 65:133-35.
9. Bunni MA, Rembiesa BM, Priest DG, Sahovic E, Stuart R. Accumulation of tetrahydro-folates in human plasma after leucovorin administration. Cancer Chemother Pharmacol 1989; 23:353-57.
10. DeVito JM, Kozloski GD, Tonelli AP, Johnson JB. Bioequivalence of oral and injectable levoleucovorin and leucovorin. Clin Pharm 1993; 12:293-99.
11. Priest DG, Schmitz JC, Bunni MA, Stuart RK. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. J Natl Cancer Inst 1991; 83:1806-12.
12. Chanarin I, Mollin DL, Anderson BB. The clearance from the plasma of folic acid injected intravenously in normal subjects and patients with megaloblastic anaemia. Br J Haematol 1958; 4:435-46.
13. Metz J, Stevens K, Krawitz S, Brandt V. The plasma clearance of injected doses of folic acid as an index of folic acid deficiency. J Clin Pathol 1961; 14:622-25.
14. 4]folic acid is a functional index of folate nutritional status. J Nutr 1998; 128:1907-12.
15. Schalhorn A, Kuhl M, Stupp-Poutot G, Nussler V. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid. Cancer Chemother Pharmacol 1990; 25:440-44.
16. Quinlivan EP, Gregory JF 3rd. Reassessing folic acid consumption patterns in the United States (1999-2004): Potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 2007; 86:1773-79.
17. Quinlivan EP, Gregory JF 3rd. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 2003; 77:221-25.
18. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001; 161:695-700.
19. van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB, Verhoef P. Folic acid and reduction of plasma homocysteine concentrations in older adults: A dose-response study. Am J Clin Nutr 2003; 77:1318-23.
20. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997; 350:1666-69.
21. Carrero JJ, Lopez-Huertas E, Salmeron LM, Baro L, Ros E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr 2005; 135:1393-99.
22. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 2006; 84:156-61.
23. Venn BJ, Green TJ, Moser R, McKenzie JE, Skeaff CM, Mann J. Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. J Nutr 2002; 132:3353-55.
24. Hao L, Yang QH, Li Z, Bailey LB, Zhu JH, Hu DJ, Zhang BL, et al. Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial. Am J Clin Nutr 2008; 88:448-57.
25. Shane B. Folate chemistry and metabolism. In: Bailey LB, ed., Folate in Health and Disease. New York: Marcel Dekker, 1995:1-22.
26. Pietrzik K, Lamers Y, Bramswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr 2007; 86:1414-19.
27. Ward M, McNulty H, McPartlin JM, Strum WB, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Q J Med 1997; 90:519-24.
28. Yang TL, Hung J, Caudill MA, Urrutia TF, Alamilla A, Perry CA, Li R, Hata H, Cogger EA. A long-term controlled folate feeding study in young women supports the validity of the 1.7 multiplier in the dietary folate equivalency equation. J Nutr 2005; 135:1139-45.
29. Homocysteine Lowering Trialist’s Collaboration. Dose-dependent effects of folic acid on blood homocysteine concentrations: A meta-analysis of the randomized trials. Am J Clin Nutr 2005; 82:806-12.
30. Neal B, MacMahon S, Ohkubo T, Tonkin A, Wilcken D. Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. Eur Heart J 2002; 23:1509-15.
31. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73:613-21.
32. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67:263-70.
33. Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlmann AM, Nau H, Berthold HK, Pietrzik K. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 2002; 75:275-82.
34. Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-meth-yltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr 2004; 79:473-78.
35. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 2004; 58:548-54.
36. Melikian V, Paton A, Leeming RJ, Portman-Graham H. Site of reduction and methylation of folic acid in man. Lancet 1971; 2:955-57.
37. Whitehead VM, Cooper BA. Absorption of unaltered folic acid from the gastro-intestinal tract in man. Br J Haematol 1967; 13:679-86.
38. Wright AJA, Finglas PM, Dainty JR, Wolfe CA, Hart DJ, Wright DM, Gregory JF. Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: A revised hypothesis of the primary site of PteGlu metabolism in humans. J Nutr 2005; 135:619-23.
39. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: Acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997; 65:1790-95.
40. Leeming RJ, Portman-Graham H, Blair JA. The occurrence of folic acid (pteroyl-L-monoglutamic acid) in human blood serum after small oral doses. J Clin Pathol 1972; 25:491-93.
41. Pfeiffer CM, Fazili Z, McCoy L, Zhang M, Gunter EW. Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologie assay. Clin Chem 2004; 50:423-32.
42. Kalmbach RD, Choumenkovitch SF, Troen AM, D’Agostino R, Jacques PF, Selhub J. Circulating folic acid in plasma: Relation to folic acid fortification. Am J Clin Nutr 2008; 88:763-68.
43. Smith AD, Kim YI, Refsum H. Is folic acid good for everyone? Am J Clin Nutr 2008; 87:517-33.
44. Pentieva K, McNulty H, Reichert R, Ward M, Strain JJ, McKillop DJ, McPartlin JM, et al. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr 2004; 134:580-85.
45. Prinz-Langenohl R, Fohr I, Tobolski O, Finglas P, Pietrzik K. Bio availability of (6S)-5-methyltetrahydrofolate relative to folic acid. Bioavailability 2001, Interlaken, Switzerland. Berlin/Heidelberg: Springer, 2001.
46. Houghton LA, Sherwood KL, Pawlosky R, Ito S, O’Connor DL. [6S]-5-Methyltetra-hydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am J Clin Nutr 2006; 83:842-50.
47. Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: A randomized placebo-controlled study. Am J Clin Nutr 2003; 77:658-62.
48. Bostom AG, Shemin D, Bagley P, Massy ZA, Zanabli A, Christopher K, Spiegel P, Jacques PF, Dworkin L, Selhub J. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Circulation 2000; 101:2829-32.
49. Mader RM, Steger GG, Rizovski B, Djavanmard MP, Scheithauer W, Jakesz R, Rainer H. Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer. Br J Clin Pharmacol 1995; 40:209-15.
50. Willems FF, Boers GH, Blom HJ, Aengevaeren WR, Verheugt FW. Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br J Pharmacol 2004; 141:825-30.
51. Russell RM, Rosenberg IH, Wilson PD, Iber FL, Oaks EB, Giovetti AC, Otradovec CL, Karwoski PA, Press AW. Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingestion. Am J Clin Nutr 1983; 38:64-70.
52. Krumdieck CL, Fukushima K, Fukushima T, Shiota T, Butterworth CE. Long-term study of excretion of folate and pterins in a human subject after ingestion of C-14 folic acid, with observations on effect of diphenylhydantoin administration. Am J Clin Nutr 1978; 31:88-93.
53. Buchholz BA, Arjomand A, Dueker SR, Schneider PD, Clifford AJ, Vogel JS. Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of C-14-labeled folic acid with accelerator mass spectrometry. Anal Biochem 1999; 269:348-52.
54. Lin YM, Dueker SR, Follett JR, Fadel JG, Arjomand A, Schneider PD, Miller JW, et al. Quantitation of in vivo human folate metabolism. Am J Clin Nutr 2004; 80:680-91.
55. Pfeiffer CM, Gregory JF. Preparation of stable isotopically labeled folates for in vivo investigation of folate absorption and metabolism. Methods Enzymol 1997; 281:106-16.
56. Gregory JF. Stable isotopic tracers for studies of folate bioavailability and metabolism: Development, principles and applications. In: G. Jansen, ed., Symposia Proceedings— Chemistry and Biology of Pteridines and Folates. Heilbronn, Germany: SPS Publications, 2007:566-83.
57. Gregory JF, Toth JP. Chemical synthesis of deuterated folate monoglutamate and in vivo assessment of urinary excretion of deuterated folates in man. Anal Biochem 1988; 170:94-104.
58. Gregory JF, Caudill MA, Opalko FJ, Bailey LB. Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: Stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools. JNutr 2001; 131:1928-37.
59. Gregory JF, Swendseid ME, Jacob RA. Urinary excretion of folate catabolites responds to changes in folate intake more slowly than plasma folate and homocysteine concentrations and lymphocyte DNA methylation in postmenopausal women. J Nutr 2000; 130:2949-52.
60. Kownacki-Brown PA, Wang CZ, Bailey LB, Toth JP, Gregory JF. Urinary excretion of deuterium-labeled folate and the metabolite p-aminobenzoylglutamate in humans. J Nutr 1993; 123:1101-08.
61. Stites TE, Bailey LB, Scott KC, Toth JP, Fisher WP, Gregory JF. Kinetic modeling of folate metabolism through use of chronic administration of deuterium-labeled folic acid in men. Am J Clin Nutr 1997; 65:53-60.
62. von der Porten AE, Gregory JF, Toth JP, Cerda JJ, Curry SH, Bailey LB. In vivo folate kinetics during chronic supplementation of human subjects with deuterium-labeled folic acid. J Nutr 1992; 122:1293-99.
63. Wright AJA, Finglas PM, Dainty JR, Hart DJ, Wolfe CA, Southon S, Gregory JF. Single oral doses of C-13 forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: Potential problems in interpretation of folate bioavailability studies. Br J Nutr 2003; 90:363-71.
64. Caudill MA, Gregory JF, Hutson AD, Bailey LB. Folate catabolism in pregnant and nonpregnant women with controlled folate intakes. J Nutr 1998; 128:204-08.
65. Bhandari SD, Gregory JF. Folic acid, 5-methyltetrahydrofolate and 5-formyltetrahydro-folate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr 1992; 122:1847-54.
66. Lakshmaiah N, Bamji MS. Half-life and metabolism of H-3-folic acid in oral contraceptive treated rats. Horm Metab Res 1981; 13:404-07.
67. Murphy M, Scott JM. Turnover catabolism and excretion of folate administered at physiological concentrations in the rat. Biochim Biophys Acta 1979; 583:535-39.
68. Pheasant AE, Connor MJ, Blair JA. The metabolism and physiological disposition of radioactively labeled folate derivatives in the rat. Biochem Med 1981; 26:435-50.
69. Butterworth CE, Baugh CM, Krumdieck C. A study of folate absorption and metabolism in man utilizing carbon-14-labeled polyglutamates synthesized by solid phase method. J Clin Invest 1969; 48:1131-42.
70. Clifford AJ, Heid MK, Muller HG, Bills ND. Tissue distribution and prediction of total-body folate of rats. J Nutr 1990; 120:1633-39.
71. Anguera MC, Stover PJ. Identification of an enzymatic folate degradation pathway. FASEB J 2001;15:A955.
72. Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr 2001; 21:255-82.
73. Anguera MC, Stover PJ. Methenyltetrahydrofolate synthetase is a high-affinity catecholamine-binding protein. Arch Biochem Biophys 2006; 455:175-87.
74. McPartlin J, Courtney G, McNulty H, Weir D, Scott J. The quantitative analysis of endogenous folate catabolites in human urine. Anal Biochem 1992; 206:256-61.
75. McPartlin JM, Weir DG, Courtney G, McNulty H, Scott JM. The level of folate catabolism in normal human populations. In: Cooper B, Whitehead V, eds., Pteridines and Folic Acid Derivatives. New York: de Gruyer, 1986: 513-16.
76. Pratt RF, Cooper BA. Folates in plasma and bile of man after feeding folic acid—H3 and 5-formyltetrahydrofolate (folinic acid). J Clin Invest 1971; 50:455-62.
77. Herbert V, Zalusky R. Interrelations of vitamin B12 and folic acid metabolism—Folic acid clearance studies. J Clin Invest 1962; 41:1263-76.
78. Gregory JF, Bailey LB, Thomas EA, Toth JP, Cerda JJ, Fisher WR. Stable-isotope study of long-term folate metabolism in a human subject. FASEB J 1994; 8:A920.
79. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. Accelerated folate breakdown in pregnancy. Lancet 1993; 341:148-49.
80. Higgins JR, Quinlivan EP, McPartlin J, Scott JM, Weir DG, Darling MRN. The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG 2000; 107:1149-54.
81. Bailey LB, Gregory JF, Caudill M, Cruz A. The relationship between increased folate stetab-olism and the increased requirement for folate in pregnancy. BJOG 2001; 108:772-73.
82. Herbert V. Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr 1987; 45:661-70.
83. Gregory JF, Bhandari SD, Bailey LB, Toth JP, Baumgartner TG, Cerda JJ. Relative bioavailability of deuterium-labeled monoglutamyl tetrahydrofolates and folic acid in human subjects. Am J Clin Nutr 1992; 55:1147-53.
84. Lucock M. Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71:121-38.
85. Jackson RC, Harrap KR. Studies with a mathematical-model of folate metabolism. Arch Biochem Biophys 1973; 158:827-41.
86. Jackson RC. Kinetic simulation of anti-cancer drug-interactions. Int J Biomed Comput 1980; 11:197-224.
87. Jackson RC. Toxicity prediction from metabolic pathway modeling. Toxicology 1995; 102:197-205.
88. Jackson RC, Harrap KR. Computer models of anti-cancer drug interaction. Pharmacol Ther 1979; 4:245-80.
89. Seither RL, Trent DF, Mikulecky DC, Rape TJ, Goldman ID. Folate pool interconversions and inhibition of biosynthetic processes after exposure of L1210 leukemia-cells to antifolates—Experimental and network thermodynamic analyses of the role of dihdydrofolate polyglutamylates in antifolate action in cell. J Biol Chem 1989; 264:17016-23.
90. White JC. Reversal of methotrexate binding to dihydrofolate reductase by dihydrofolate— Studies with pure enzyme and computer modeling using network thermodynamics. J Biol Chem 1979; 254:889-95.
91. Martinov MV, Vitvitsky VM, Mosharov EV, Banerjee R, Ataullakhanov FI. A substrate switch: A new mode of regulation in the methionine metabolic pathway. J Theor Biol 2000; 204:521-32.
92. Prudova A, Martinov MV, Vitvitsky VM, Ataullakhanov FI, Banerjee R. Analysis of pathological defects in methionine metabolism using a simple mathematical model. Biochim Biophys Acta 2005; 1741:331-38.
93. Nijhout HF, Reed MC, Budu P, Ulrich CM. A mathematical model of the folate cycle: New insights into folate homeostasis. J Biol Chem 2004; 279:55008-16.
94. Reed MC, Nijhout HF, Sparks R, Ulrich CM. A mathematical model of the methionine cycle. J Theor Biol 2004; 226:33-43.
95. Reed MC, Nijhout HF, Neuhouser ML, Gregory JE, Shane B, James SJ, Boynton A, Ulrich CM. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 2006; 136:2653-61.
96. Nijhout HF, Reed MC, Lam S-L, Shane B, Gregory JF 3rd, Ulrich CM. In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theor Biol Med Model 2006; 3:40.
97. Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JF III, Shane B, James SJ, Reed MC, Nijhout HF. Mathematical modeling of folate metabolism: Predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev 2008; 17:1822-31.
98. 13C]methionine. Am J Physiol 1988; 255:E322-31.
99. 3]Methionine kinetics in humans: Methionine conservation and cystine sparing. Am J Physiol 1990; 258:E790-98.
100. Millward DJ. Vernon Young and the development of current knowledge in protein and amino acid nutrition. Vernon Young 1937-2004. Br J Nutr 2004; 92:189-97.
101. Davis SR, Scheer JB, Quinlivan EP, Coats BS, Stacpoole PW, Gregory JF 3rd. Dietary vitamin B-6 restriction does not alter rates of homocysteine remethylation or synthesis in healthy young women and men. Am J Clin Nutr 2005; 81:648-55.
102. Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, Shane B, Bailey LB, Gregory JF 3rd. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am J Physiol Endocrinol Metab 2004; 286:E272-E279; Erratum 2004; 286:E674.
103. Fukagawa NK, Yu YM, Young VR. Methionine and cysteine kinetics at different intakes of methionine and cysteine in elderly men and women. Am J Clin Nutr 1998; 68:380-88.
104. Raguso CA, Pereira P, Young VR. A tracer investigation of obligatory oxidative amino acid losses in healthy, young adults. Am J Clin Nutr 1999; 70:474-83.
105. 13C]methionine as a tracer. Am J Clin Nutr 1991; 54:377-85.
106. Raguso CA, Regan MM, Young VR. Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adults. Am J Clin Nutr 2000; 71:491-99.
107. van Guldener C, Kulik W, Berger R, Dijkstra DA, Jakobs C, Reijngoud DJ, Donker AJ, Stehouwer CD, De Meer K. Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 1999; 56:1064-71.
108. 13C]methionine. Am J Clin Nutr 1991; 54:386-94.
109. MacCoss MJ, Fukagawa NK, Matthews DE. Measurement of intracellular sulfur amino acid metabolism in humans. Am J Physiol Endocrinol Metab 2001; 280:E947-55.
110. Cuskelly GJ, Stacpoole PW, Williamson J, Baumgartner TG, Gregory JF 3rd. Deficiencies of folate and vitamin B(6) exert distinct effects on homocysteine, serine, and methionine kinetics. Am J Physiol Endocrinol Metab 2001; 281:E1182-90.
111. 3]serine allows in vivo kinetic measurement of serine turnover, homocysteine remethylation, and transsulfuration processes in human one-carbon metabolism. Am J Clin Nutr 2000; 72:1535-41.
112. Davis SR, Quinlivan EP, Shelnutt KP, Ghandour H, Capdevila A, Coats BS, Wagner C, et al. Homocysteine synthesis is elevated but total remethylation is unchanged by the methylenetetrahydrofolate reductase 677C→T polymorphism and by dietary folate restriction in young women. J Nutr 2005; 135:1045-50.
113. 3]leucine. J Nutr 2007; 137:2647-52.
114. Quinlivan EP, Davis SR, Shelnutt KP, Henderson GN, Ghandour H, Shane B, Selhub J, Bailey LB, Stacpoole PW, Gregory JF 3rd. Methylenetetrahydrofolate reductase 677C→T polymorphism and folate status affect one-carbon incorporation into human DNA deoxynucleosides. J Nutr 2005; 135:389-96.
115. Lamers Y, Williamson J, Ralat M, Quinlivan EP, Gilbert LR, Keeling C, Ueland PM, et al. Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations, increases in vivo serine production from glycine, while minimally affecting the rates of glycine turnover, glycine cleavage and related aspects of 1-carbon metabolism in healthy men and women. JNutr 2009; 139:452-60.
116. Scheer JB, Mackey AD, Gregory JF 3rd. Activities of hepatic cytosolic and mitochondrial forms of serine hydroxymethyltransferase and hepatic glycine concentration are affected by vitamin B-6 intake in rats. J Nutr 2005; 135:233-38.
117. Davis SR, Quinlivan EP, Stacpoole PW, Gregory JF 3rd. Plasma glutathione and cystathionine concentrations are elevated but cysteine flux is unchanged by dietary vitamin B-6 restriction in young men and women. J Nutr 2006; 136:373-78.
118. Lima CP, Davis SR, Mackey AD, Scheer JB, Williamson J, Gregory JF 3rd. Vitamin B-6 deficiency suppresses the hepatic transsulfuration pathway but increases glutathione concentration in rats fed AIN-76A or AIN-93G diets. J Nutr 2006; 136:2141-47.